OTLC · Oncotelic Therapeutics, Inc. · Investor Relations
$0.02
0.00 (-4.86%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$9.15M
Shares
457.51M
Volume · Oct 20
227.04K
Avg daily vol (3M)
311.29K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2022-02-11 | Biotechgate Digital Partnering February 2022 (7 – 11 Feb, 2022) Learn more > | Event |
| 2022-01-25 | 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit (tgf-beta-summit.com) (January 25, 2022 to January 27, 2022) Learn more > | Event |
| 2021-10-26 | Oncotelic Therapeutics Investor Presentation 10-26-2021. Learn more > | Presentation |